Members
The Science Advisory Board (SAB) consists of a Chair, a Vice-Chair
and up to 16 members. The members of the Board are appointed by
the Minister of Health. They are individuals outside of the federal
government who have scientific knowledge, experience and expertise
relevant to the mandate of Health Canada.
Nominations for membership to the Board come from a variety of
sources including self-nominations, Board members, departmental
officials and management. The Assistant Deputy Ministers, the Chief
Scientist and the Chair review and develop the slate of nominees
and make recommendations to the Deputy Minister and the Minister.
This section features a short biography of each of the current
members of the Science Advisory Board.
Current Members December 2005
Biographies of Members (terms in parentheses)
Arnold Naimark - Chair (June 2005 - June 2008)
Arnold Naimark graduated from the University of Manitoba in 1957 with a medical degree. He then received his Master of Science in 1959 followed by several international research fellowships. Dr. Naimark, a Specialist in Internal Medicine, was admitted by examination to the Fellowship in the Royal College of Physicians and Surgeons of Canada in 1964. He had a distinguished career as a Professor of Medicine and Physiology at the University of Manitoba before becoming Dean of the Faculty of Medicine from 1971 to 1981, following which he served as the President and Vice-Chancellor of the University from 1981 to 1996. He is currently Professor, Dean Emeritus and Director of the Centre for the Advancement of Medicine at the University of Manitoba .
Throughout his career, Dr. Naimark has been a medical, academic, and community leader in numerous local, national and international organizations. He has served as: Founding Chair, Canadian Biotechnology Advisory Committee (CBAC); Founding Chair, Canadian Health Services Research Foundation; and President or Chairman of the Canadian Physiological Society, the Canadian Society for Clinical Investigation, the Association of Canadian Medical Colleges, the Association of Universities and Colleges of Canada, and the Association of Commonwealth Universities. He is a member of the Board of the Robarts Research Institute, the Research Council of the Canadian Institute for Advanced Research, the National Statistics Council, and the boards of Medicure Inc., CancerCare Manitoba and the Manitoba Lung Association. Dr Naimark is the recipient of several honorary degrees and awards.
Linda Lusby - Vice Chair (May 2001 - May 2007)
Linda Lusby is an Associate Professor of Environmental Science at Acadia University in Wolfville Nova Scotia. Her academic background includes a BHEc from Mount Saint Vincent University, a Masters in Science (MSc) from the University of Alberta and an LLB from Dalhousie University. She is currently a PhD candidate at Imperial College of Science, Technology and Medicine, London and expects to defend in late 2004. Her dissertation, entitled Agricultural Biotechnology - A Regulatory Analysis Introducing a Draft Model Code involves a comparative analysis of governance issues in biotechnology and develops and tests a model code presenting a harmonized approach to risk management, precaution and assignment of liability.
Professor Lusby has been an active participant in national, regional and international standards organizations for many years. She served as the Chair of the Standards Council of Canada from 1998 - 2001 and in that capacity represented Canada on the Council and Technical Management Board of International Standards Organization (ISO) and chaired an international ad hoc committee on privacy. During her tenure as Chair she was instrumental in the development of Canada's first National Standards Strategy. In 2001 - 2002 she served as President of the Pan American Standards Commission. Currently she is a member of the Board of Directors of Canadian Standards Association (CSA) Group and serves on and/or chairs a number of standing committees and sub-boards of that organization.
Professor Lusby is Vice-Chair of the Science Advisory Board for Health Canada and serves on the Science and Technology Advisory Board Panel on Environment and Health for Environment Canada. She was appointed to the Canadian Biotechnology Advisory Committee in 2003. She is a Fellow of Leadership for Environment and Development (LEAD) International and a member of the core group on food security for that organization. She received a University of Alberta Alumni Honours Award in 2000 for distinguished professional and community service.
Lorne Babiuk (November 2003 - November 2006)
Dr. Babiuk received his DSc in Virology/Immunology at the University of Saskatchewan (1987) and his PhD in Virology at the University of British Columbia (1972). Dr. Lorne Babiuk is Director of the Veterinary Infectious Disease Organization (VIDO) in Saskatoon (1993-present) and a Professor of Veterinary Microbiology at the University of Saskatchewan (1979-present). Dr. Babiuk was previously Associate Director (Research) at VIDO (1984-93) and Coordinator, Respiratory Disease Program, VIDO (1980-86).
He was an Associate Professor (1975-79) and Assistant Professor (1973-75) in the Department of Veterinary Microbiology at the University of Saskatchewan. Dr. Babiuk is the author of more than 300 manuscripts and 63 book chapters or review articles, holder of 11 patents and 8 pending patents, and winner of 28 awards including, most recently, the National Merit Award, Ottawa Life Sciences (1998) and the Pfizer Prize in Animal Health (1998).
Dr. Babiuk serves on numerous national and international committees including the Canadian Biotechnology Advisory Committee (CBAC), the Natural Sciences and Engineering Research Council (NSERC), the Xeno Transplantation Committee and the Canada Foundation for Innovation, and held the first NSERC Chair in Biotechnology (1985-95).
Keith Bailey (September 2002 - September 2008)
Dr. Bailey is a private citizen with thirty years' experience of public service in scientific research, policy development, and executive management at Health Canada.
His formal education was at St Catherine's College Oxford, in the Honour School of Natural Science- Chemistry: B.A., 1963; D. Phil., 1965. Following two years of post-doc teaching and research at Oxford and two years at Trent University, he joined Health Canada as a Research Scientist.
In the Food and Drugs Directorate, he was first engaged by the research laboratories in the synthesis, physicochemical characterization and pharmacological quantitative structure-activity relationships (QSAR) and forensic assessment of classical and novel psychotropic substances. He became Chief of the Drug Identification Division and subsequently the Drug Toxicology Division before appointment as Bureau Director, Drug Research Laboratories (renamed Bureau of Drug Research) in 1984. He published over 50 original articles in scientific journals and presented over 100 reports at scientific conferences during a twenty year active research career.
He was Director, Bureau of Drug Research from 1984 -1994 and Director of the Bureau of Biologics and Radiopharmaceuticals from 1994. As a senior manager with the Therapeutic Products Programme (TPP), Dr Bailey was intimately involved in developing TPP's policy course and Programme strategy, and effecting policies at the Bureau and Programme level. He chaired several key committees at Programme (ex.: TPP Policy Committee) and Health Protection Branch (ex.: Health Portection Bracnh Biotechnology Committee) level. His recent focus as Director, Bureau of Biologics and Radiopharmaceuticals, was particularly on life sciences and the impact of the rapidly-advancing areas of molecular genetics, blood safety, and xenotransplantation on regulatory science and risk/benefit assessment.
Following retirement from Health Canada, Dr Bailey has provided services as a consultant to the Therapeutic Products Directorate and the Biologics and Genetic Therapies Directorate, and to other government Departments (Canada Customs and Revenue Agency, Department of Justice). He has provided scientific and regulatory advice to large and small pharmaceutical and biotechnology companies.
Renaldo Battista (February 2005 - February 2008)
Dr. Battista is Professor and Director of the Department of Health Administration (DASUM), Faculty of Medicine, University of Montreal. He was president of the Conseil d'évaluation des technologies de la santé (CÉTS) from 1994 to 2000, and President and Chief Executive Officer (CEO) of the Agence d'évaluation des technologies et des modes d'intervention en santé (AÉTMIS), from 2000 to 2004. From 1982 to 2003, he was on staff in the Departments of Epidemiology and Biostatistics, and Medicine at McGill University.
An internationally recognized expert in his field, Dr. Battista has been a member of the Scientific Board of the Agence nationale pour le développement de l'évaluation médicale (ANDEM) Paris, the Board of Directors of the Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Ottawa and the Scientific Advisory Board of the Catalan Agency for Health Technology Assessment (CAHTA), Barcelona.
He also served as President of the International Society of Technology Assessment in Health Care (ISTAHC 1995-97), and member of the Advisory Board of the Institute of Health Services and Policy Research of the Canadian Institutes of Health Research (CIHR) 2001- 03.
Dr. Battista has authored more than 100 articles and book chapters in the fields of preventive medicine, clinical epidemiology, and health services research.
Stephen Bornstein (December 2005 - December 2008)
Dr. Stephen Bornstein, comes to Memorial University from McGill University and brings with him a varied background. After receiving his Ph.D. from Harvard University in Government in 1979, Dr. Bornstein began teaching at McGill University in the Political Science Department. He also served as Associate Dean of Graduate Studies in 1990. From 1991 through 1995, Dr. Bornstein took an extended leave from university teaching and administration to work with the Ontario provincial government in the Ministry of Intergovernmental Affairs as Assistant Deputy Minister and Ontario Representative to Quebec. Dr. Bornstein’s areas of academic expertise are comparative politics and public policy and comparative labour relations and his area of geographical specialization has been Western Europe. In recent years, he has shifted his focus to Canadian public policy and, in particular, Canadian health policy. He is currently Professor of Political Science at Memorial University and Director of the Newfoundland Centre for Applied Health Research.
Mark Goldberg (November 2003 - November 2006)
Dr. Goldberg is an occupational and environmental epidemiologist. He obtained a BSc in physics (1975), a MSc degree (1985) and PhD degree (1991) in epidemiology and biostatistics from McGill University. From 1990 until 1996, he worked in the Montreal public health department as an epidemiologist and, from 1996-2000, he was a professor at the l'Institut national de la recherche scientifique (INRS) - Institut Armand-Frappier, University of Quebec.
He is currently an associate professor at McGill University in the Department of Medicine and associate member in the Department of Epidemiology and Biostatistics, Department of Occupational Health, in the Department of Oncology, and the McGill School of Environment. He holds a Chercheur-Boursier from the Fonds de recherche en santé du Québec and an Investigator Award from the Canadian Institutes for Health Research.
Arminée Kazanjian (February 2005 - February 2008)
Arminée Kazanjian, is Professor, Department of Health Care and Epidemiology, Faculty of Medicine, University of British Columbia (UBC). A Sociologist by training, she was founding Director of the British Columbia Office of Health Technology Assessment at UBC (1991-2002), and served as Director of the Health Human Resources Unit at UBC from 1988 to 2002. She was also Associate Director, Centre for Health Services & Policy Research, UBC, 1988-2002. Dr. Kazanjian served on the BC Health Professions Council from 1991-2001, a cabinet appointed advisory body that reviewed existing health professions' regulation and made recommendations for shared scopes of practice to the BC Minister of Health. She has also served on the Federal/Provincial/Territorial Advisory Committee on Health Human Resources for many years.
Dr. Kazanjian is an internationally recognized Health Services Researcher whose work incorporates the social and cultural dimensions of care seeking and service provision, technology diffusion and implications for population groups, and factors supporting knowledge translation and the use of research evidence in policy decisions. Current major areas of research interest include: gender and healthcare utilization, women's health indicators, immigrant health and heath care utilization, and understanding rural health and its determinants. In addition, her areas of research include health workforce modelling, and the evaluation of health workforce policy.
Andreas Laupacis (February 2005 - February 2008)
Dr. Laupacis is a General Internist. In September 2000, he became President and Chief Executive Officer of the Institute for Clinical Evaluative Sciences (ICES) in Toronto and a Professor in the Departments of Medicine and Health Policy Management and Evaluation at the University of Toronto.
Dr. Laupacis received his medical degree from Queen's University. He did his internship at Dalhousie and residency in internal medicine at the University of Western Ontario.
His research training includes two years as a Medical Research Council of Canada (MRC) Research Fellow with Dr. Calvin Stiller at the University of Western Ontario studying the efficacy of cyclosporine as an immunosuppressant in transplantation and diabetes. He also has a Masters degree in Design, Measurement and Evaluation from McMaster University. He worked at the University of Western Ontario (1986 - 1991) and the University of Ottawa (1991 - 2000) prior to moving to Toronto.
Dr. Laupacis' initial research interests were in the design and execution of multi-centre clinical trials, evaluating methods of presenting the results of clinical trials to patients and clinicians, and health care technology assessment. Contributions that Dr. Laupacis has made to the literature include a) articulation of the number needed to treat (with David Sackett), b) studies of anti-thrombotic therapy to prevent stroke in patients with atrial fibrillation (with numerous collaborators), c) evaluation of the role of erythropoietin in patients with end stage renal failure (with Paul Keown and others), and d) the development of decision aids for patients and physicians (with Annette O'Connor and colleagues at Ottawa). More recently, he has become involved in the areas of pharmacoeconomics, drug policy and the use of diagnostic tests.
He was the first recipient of a Fellowship of the International Society of Technology Assessment in Health Care (ISTAHC), and later served on its Board and as Treasurer. Dr. Laupacis has published over 200 articles in peer-reviewed journals and is a Senior Scientist of the Canadian Institutes of Health Research. As his hair has greyed, he has served on an increasing number of committees including the Drug Quality and Therapeutics Committee (DQTC) of the Ontario Ministry of Health and Long-Term Care, the Ontario Drug Strategy Review, and the Ontario Expert Panel on Infectious Disease Control which reviewed the impact of Severe Acute Respiratory Syndrome (SARS) on the Ontario health care system. He is currently Chair of the Canadian Expert Drug Advisory Committee (CEDAC).
Louise Lemieux-Charles (December 2005 - December 2008)
Dr. Louise Lemieux-Charles is Chair and Associate Professor of the Department of Health Policy, Management and Evaluation in the Faculty of Medicine, University of Toronto; Director of the Hospital Management Research Unit, a health-system linked unit in Ontario; and Adjunct Scientist with the Institute for Work and Health. She holds a PhD in organizational theory and management. Her research interests are in the areas of performance management including organization and team effectiveness, organizational learning, knowledge transfer, quality of work life and the organization of health systems. She currently holds a number of research grants totaling 1.5 Million dollars examining organizational performance and issues of evidence and decision-making in health-care and recently co-edited a book entitled Using Knowledge and Evidence in Health Care: A Multidisciplinary Perspective. She was one of the co-leaders of HEALNet, a Canadian Network of Centres of Excellence dedicated to research on optimizing the use of research funding to improve decisions in the health system. She is actively involved in several granting councils including Canadian Health Services Research Foundation and Canadian Institutions of Health Research and in 2004 was a member of the Canadian Foundation for Innovation Oversight Committee. She has been active as a Board member in hospital and community-based agencies (United Way of Greater Toronto).
Chris Loomis (November 2003 - November 2006)
Dr. Loomis received his PhD from Queen's University in 1983, and joined the School of Pharmacy of Memorial University as an associate professor in 1988, and was appointed director of Memorial's School of Pharmacy in 1998. Since 1984, Dr. Loomis has been funded by the Canadian Institutes of Health Research (CIHR), formerly the Medical Research Council (MRC) for his research on the spinal pharmacology of pain, and he is the author of many papers and presentations on this subject.
He is a former member and officer of several MRC/CIHR peer-review committees, and was Memorial's first MRC regional director. He has served as a member of the College of Reviewers for the Canada Research Chairs Program, as president of the Association of Deans of Pharmacy of Canada, and he is currently a member of Canada's Research-based Pharmaceutical Companies (Rx&D) Health Research Foundation Advisory Council. Dr. Loomis twice received the Bristol Myers-Squibb Award for Excellence in Pharmaceutical Teaching, and the Dr. Albert R. Cox Research Award from Memorial University. Dr. Loomis was recently named Memorial University's vice-president (research and international relations).
Renee Lyons (February 2005 - February 2008)
Dr. Lyons is Professor and Director of the Atlantic Health Promotion Research Centre (AHPRC) at Dalhousie University with appointments in the School of Health and Human Performance (major) and the Department of Psychology; and a theme co-leader for the Canadian Stroke Network, National Centres of Excellence (NCE), University of Ottawa. She has been a faculty member at Dalhousie University for the past 23 years. Prior to 1981, she held several management positions in clinical and community development to support the health and quality life of persons with chronic illness and disabilities. She received her university education at Dalhousie University, Xavier University (Cincinnati), the University of Oregon, and University of California Los Angeles (UCLA). She is currently principal investigator for $6M in research funding for large health promotion projects that involve inter-sectoral, inter-disciplinary collaboration.
Dr. Lyons has been a world leader in health promotion research, particularly related to environmental diagnostics in health promotion as applied to chronic illness. Her work has contributed to theoretical development, issues clarification, and action to improve the health and social integration of individuals with chronic health problems and disabilities. She has also advanced the field of stress and coping by using her work on chronic illness to develop the theory of communal coping. She has assumed leadership roles within the International Society for Relationship Research, Canadian Institutes of Health Research (Special Advisor to the President), Industry Canada, the Social Sciences and Humanities Research Council, the Heart and Stroke Foundation, and in Atlantic Canada, via the Atlantic Health Promotion Research Centre. The July, 2002, edition of Canadian Living Magazine named Dr. Lyons as one of 10 Medical Megastars in Canada, acknowledging the important role that health promotion research (and the research of AHPRC) plays in the health of Canadians.
Kathryn O'Hara (September 2002 - September 2008)
Ms. O'Hara is a faculty member of the School of Journalism and Communication at Carleton University in Ottawa. She is the first person to hold the School's Canadian Television (CTV) Chair in Science Broadcast Journalism, the first such chair of its kind in anglophone Canada. She holds an MSc in Science Communication from The Queen's University of Belfast.
A long-standing broadcast journalist, Ms. O'Hara is the former consumer columnist with Canadian Broadcasting Corporation (CBC) Midday, the former anchor of CBC's Newsday in Ottawa, and the former host of Later the Same Day, CBC Radio Toronto's "drive-home" program. Her work appeared on the CBC's Quirks and Quarks and Ideas programs. For the three years before coming to the Carleton School of Journalism and Communication, she was an independent health and science documentary producer for outlets such as Radio Telefís Éireann (RTE) Ireland and CBC.
Howard A. Palley (December 2005 - December 2008)
Dr. Howard A. Palley is a professor of social policy at the School of Social Work and a distinguished fellow at the Institute for Human Services Policy at the University of Maryland, Baltimore. He is co-author of The Chronically-Limited Elderly: The Case for a National Policy of In-Home and Supportive Community-Based Care. He has authored or co-authored a number of studies of health service delivery policies in the United States, Canada, Sweden and Israel. He also has authored or co-authored articles on social policies for the elderly in the United States, Korea, Japan and Ukraine. His publications have appeared in International Journal of Health Services, Journal of Health and Social Policy, Social Policy and Administration, Social Service Review, Inquiry, Health and Social Work, and Journal of Aging and Social Policy. He has received Fulbright awards to the Republic of Korea, Taiwan and Ukraine. Professor Palley received a PhD in public policy for the Maxwell School of Citizenship and Public Affairs, Syracuse University.
Rémi Quirion (December 2005 - December 2008)
Dr. Rémi Quirion is a McGill University Full Professor and Scientific Director at the Douglas Hospital Research Centre (a McGill affiliated teaching hospital). Under his leadership, the Douglas Hospital Research Centre became a premier research facility in Canada in the fields of neurosciences and mental health. Dr. Quirion promoted the development of neurosciences and clinical research in Neurology and Psychiatry as well as social and evaluation aspects of research in mental health and addiction. His research interests include: a) understanding the relationships between key phenotypes of the Alzheimer’s brain; and, b) molecular and pharmacological features of neuropeptide receptors focussing on neuropeptide Y and calcitonin-gene related peptide, and their role in memory, pain and drug dependance, and in animal models of schizophrenia. His major interest lies in the training of the next generation of scientists. In addition to being on the Advisory Board of over 15 scientific journals in Psychiatry, Pharmacology, and Neurosciences, Dr. Quirion has published 5 books and more than 500 scientific papers and articles.
Dr. Quirion is the inaugural Scientific Director of the Institute of Neurosciences, Mental Health and Addiction, one of the 13 virtual institutes of the Canadian Institutes of Health Research created in 2000. Moreover, Dr. Quirion is one of the most highly cited neuroscientists in the world, in addition to being Fellow of the Royal Society of Canada and a ‘’Chevalier’‘ of the ‘’Ordre national du Québec’‘. He also received in 2003, the ‘’Médaille de l’Assemblée nationale du Québec’‘ and the ‘’2003 First Annual Award – National Mental Health Champion (Research)’‘. In 2004 he received the ‘’Wilder-Penfield Award, Prix du Québec’‘, the highest distinction in Biomedical Research in Quebec, as well as a Heinz-Lehmann Award from the Douglas Hospital Foundation, and the Dr. Mary V. Seeman Award from the Canadian Psychiatric Research Foundation. He has recently been appointed Fellow of the Canadian Academy of Health Sciences.
Jacques Simard (February 2005 - February 2008)
Jacques Simard is chairholder of the Canada Research Chair in Oncogenetics, Professor at the Department of Anatomy-Physiology at Laval University and Director of the Cancer Genomics Laboratory at Centre hospitalier de l'Université Laval (CHUL) Research Center of the Centre Hospitalier Universitaire de Québec. His career as an independent investigator began in 1990. A major emphasis of his research program has been the structure, function and regulation of enzymes involved in the biosynthesis of steroid hormones, as well as the characterization of the molecular basis of a form of congenital adrenal hyperplasia and male pseudohermaphroditism. In parallel, he was involved in the identification of susceptibility genes for breast, ovarian and/or prostate cancers. In acknowledgment of his outstanding contributions, he received in 1999 the most prestigious recognition for a scientist younger than 40, awarded by the Endocrine Society, an international organization of more than 9000 members. More recently, he received the Prix d'excellence 2004 de la Fondation de la recherche sur les maladies infantiles. He was author on more than 150 original publications and 89 reviews and book chapters.
He is Director of the INterdisciplinary Health Research International Team on BReast CAncer susceptibility (INHERIT BRCAs) funded by the Canadian Institutes for Health Research since January 2001, which includes 18 principal investigators from seven universities in three countries. This team performs studies in cancer genomics and in human genetics as well as in clinical and molecular epidemiology. The INHERIT BRCAs also explores the concerns related to the impact of cancer genetic tests on longterm quality of life, the compliance with screening recommendations, and health-care utilization as well as legal and socio-ethical implications of cancer genetic testing, such as issues of confidentiality and discrimination, particularly access to insurance. This team received the Mérites du CQLC 2003 awarded by the Conseil Québecois de Lutte Contre le Cancer, an agency of the Ministère de la Santé du Québec. He also Director and founder of the Oncogenetics axis of the Applied Medical Genetics Network of the Fonds de la recherche en santé Québec (FRSQ). He is also the co-leader in the development of a national strategy to improve evidence-based clinical service delivery and enhance integrated collaborative research for hereditary cancers. He was either a member or chairman of numerous peer review panels of several funding agencies. He was a member of the Medical Research Council of Canada and the Institute Advisory Board of the Canadian Institutes for Health Research (CIHR) Gender and Health Institute. He is currently on the priorities and planning committee: Gene to Predictive Genomic Medicine of the CIHR Institute of Genetics as well as on and the Research Policy Advisory Committee of the Canadian Association of Provincial Cancer Agencies.
Stanley Vollant (September 2003 - September 2006)
Dr. Stanley Vollant is a skilled surgeon from the Montagnais community of Betsiamites, and is Head of General Surgery at the Centre Hospitalier Régional Baie-Comeau . He was nominated as a model Aboriginal person in February 1996 by the Governor General of Canada. A major concern for Dr. Vollant is the health of First Nations people. He feels that Aboriginal people have specific problems that require specific solution.
He was the President of the Quebec Medical Association from 2001 to 2003, becoming the first Aboriginal physician to lead a provincial medical association and the first Aboriginal person to become a board member of the Canadian Medical Association. As President, he was responsible for upholding the professional values of 6,000 of the 14,000 doctors in the province.
Mamoru (Mo) Watanabe (December 2005 - December 2008)
Dr. Mo Watanabe is Emeritus Professor of Medicine and former Dean of the Faculty of Medicine of the University of Calgary. He is recognized nationally and internationally for his leadership roles in health care, health policy, health research, physician workforce, rural health, medical education, information and communications technology and telehealth. He has been involved in countless committees, councils and task forces addressing these important issues. Some highlights include serving as a member of the Prime Minister's National Forum on Health from 1994-97, serving in various capacities with the Medical Research Council (MRC) where, as Director of Health Research from 1994-95, he led the effort to broaden the base of MRC’s research to include health services, population health, and psychosocial research. An expert on physician workforce planning, he chaired the Committee on Physician Resources for the Canadian Medical Association and chaired the Manpower Steering Subcommittee and the Research Group on Physician Resources in Health for the Canadian Medical Forum. In the area of health information and communications technology and telehealth, he has served on various councils and committees for Industry Canada, Health Canada, and the Conference Board of Canada and has worked with European Union partners on cooperation in health telematics.
Dr. Watanabe has been recognized for his many contributions and was appointed an Officer of the Order of Canada in October 2001 for lifetime achievement. He was recently named as one of Alberta’s 100 Physicians of the Century and a Fellow of the Canadian Academy of Health Sciences.
|
